Changzhou Qianhong Biopharma Co Ltd (002550) — Cash Flow Reinvestment Rate
Changzhou Qianhong Biopharma Co Ltd (002550) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting CN¥15.58 Million (capex CN¥15.58 Million ) from operating cash flow of CN¥156.34 Million. Check Changzhou Qianhong Biopharma Co Ltd (002550) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Changzhou Qianhong Biopharma Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Changzhou Qianhong Biopharma Co Ltd across 18 annual periods. Explore 002550 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Changzhou Qianhong Biopharma Co Ltd. For live market cap and broader valuation context, see 002550 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | CN¥300.22 Million | CN¥361.36 Million | CN¥141.60 Million | ▲ +159.4% |
| 2024 | 0.32x | CN¥164.85 Million | CN¥514.71 Million | CN¥90.64 Million | ▼ -38.0% |
| 2023 | 0.52x | CN¥275.43 Million | CN¥533.33 Million | CN¥100.33 Million | ▼ -80.0% |
| 2021 | 2.58x | CN¥267.60 Million | CN¥103.56 Million | CN¥90.37 Million | ▲ +48.4% |
| 2020 | 1.74x | CN¥552.42 Million | CN¥317.28 Million | CN¥62.53 Million | ▼ -3.3% |
| 2019 | 1.80x | CN¥290.94 Million | CN¥161.55 Million | CN¥100.68 Million | ▼ -87.4% |
| 2018 | 14.28x | CN¥363.35 Million | CN¥25.45 Million | CN¥103.53 Million | ▲ +844.2% |
| 2017 | 1.51x | CN¥133.87 Million | CN¥88.52 Million | CN¥87.63 Million | ▲ +75.0% |
| 2016 | 0.86x | CN¥190.95 Million | CN¥221.01 Million | CN¥138.94 Million | ▼ -46.6% |
| 2015 | 1.62x | CN¥463.42 Million | CN¥286.50 Million | CN¥215.78 Million | ▲ +350.3% |
| 2014 | 0.36x | CN¥90.53 Million | CN¥252.01 Million | CN¥90.53 Million | ▼ -54.8% |
| 2013 | 0.80x | CN¥127.59 Million | CN¥160.47 Million | CN¥127.59 Million | ▲ +147.5% |
| 2012 | 0.32x | CN¥64.20 Million | CN¥199.82 Million | CN¥64.20 Million | ▲ +79.3% |
| 2011 | 0.18x | CN¥26.31 Million | CN¥146.82 Million | CN¥26.31 Million | ▲ +188.9% |
| 2010 | 0.06x | CN¥10.64 Million | CN¥171.51 Million | CN¥10.64 Million | ▼ -96.1% |
| 2009 | 1.60x | CN¥13.37 Million | CN¥8.35 Million | CN¥13.37 Million | ▲ +1075.1% |
| 2008 | 0.14x | CN¥7.41 Million | CN¥54.36 Million | CN¥7.41 Million | ▼ -29.6% |
| 2007 | 0.19x | CN¥6.97 Million | CN¥35.99 Million | CN¥6.97 Million | — |